9. Conclusion
The present Action Plan was formulated from the perspective of steady promotion
of the Action Plan (Version 1) that was formulated in December 2019, on the basis
of the discussions that have been held to date and against the backdrop of recent
global advances in research using whole genome information and the increasing
importance of projects relating to whole genome analysis in Japan. The present
Action Plan clarifies the objectives of the project for whole genome analysis, and
also sets out the basic policies.
The individual initiatives will be promoted in line with the objectives of the
project, with the aim of overcoming cancer and rare/intractable diseases in the
future.
The Expert Committee will continue to check the progress of the initiatives
and changes in the environment relating to industry and academe, and will respond
as necessary.
Furthermore, the way the Project Implementation Organization operates and
matters relating to ELSI and PPI require continuous examination that goes beyond
the items for examination in the present Action Plan, and the Expert Committee will
continue to discuss these issues.
In addition, from a broader perspective it would be desirable to give urgent
consideration to specific exit strategies to put in place an environment for utilization
of data by industry and academe, promote innovative drug discovery and research,
and deliver high-quality medical care to patients.

53